Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and healthcare investment firm Gurnet Point closed their acquisition of US antibiotics specialist...
Sandoz, the generics arm of Swiss drugmaker Novartis, has announced plans to spend an additional €50 million on raising European manufacturing capacity for finished...
30.10.2017
- As antibiotic resistance becomes an increasingly urgent threat to public health, pharmaceutical firms Roche and Warp Drive Bio have joined forces to develop novel classes of the...
26.08.2016
- With plenty of cash still in the kitty after a failed attempt last April to buy Allergan for $160 million and move its headquarters to Ireland, Pfizer continues to pound the...
06.07.2016
- Evonik has agreed to buy the probiotics business of Spanish animal feed ingredients producer Norel for an undisclosed sum. The deal includes the company’s probiotics portfolio as...
24.03.2016
- Expressing serious concerns about the carcinogenicity and endocrine disruptive properties of the herbicide active ingredient glyphosate, the European Parliament’s Environment (ENVI...
26.01.2016
- More than 80 international drug and biotechnology companies have urged governments to work with them to combat the emergence of drug-resistant superbugs, according to a report by...
14.01.2016
- French drugmaker Sanofi has simultaneously announced collaborations with two biotechnology firms, together worth up to €1.2 billion. The first link-up, worth $750 million (€690...
